{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T23:04:42Z","timestamp":1772233482337,"version":"3.50.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2005,10,1]],"date-time":"2005-10-01T00:00:00Z","timestamp":1128124800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Oncol Rep"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1007\/s11912-005-0062-5","type":"journal-article","created":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T16:21:21Z","timestamp":1180714881000},"page":"357-363","source":"Crossref","is-referenced-by-count":41,"title":["Diffuse large B-cell lymphomas with plasmablastic differentiation"],"prefix":"10.1007","volume":"7","author":[{"given":"Julie","family":"Teruya-Feldstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"62_CR1","volume-title":"Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues","author":"E Jaffe","year":"2001","unstructured":"Jaffe E, Harris N, Stein H, Vardiman J: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001."},{"key":"62_CR2","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1182\/blood.V89.4.1413","volume":"89","author":"HJ Delecluse","year":"1997","unstructured":"Delecluse HJ, Anagnostopoulos I, Dallenbach F, et al.: Plasmablastic lymphomas of the oral cavity: a new entity associated with the human immunodeficiency virus infection. Blood 1997, 89:1413\u20131420.","journal-title":"Blood"},{"key":"62_CR3","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1093\/annonc\/mdh399","volume":"15","author":"J Teruya-Feldstein","year":"2004","unstructured":"Teruya-Feldstein J, Chiao E, Filippa DA, et al.: CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients. Ann Oncol 2004, 15:1673\u20131679.","journal-title":"Ann Oncol"},{"key":"62_CR4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2559.2005.02068.x","volume":"46","author":"L Leoncini","year":"2005","unstructured":"Leoncini L, Delsol G, Gascoyne RD, et al.: Aggressive B-cel lymphomas: a review based on the workshop of the XI Meeting of the European Association for Haematopathology. Histopathology 2005, 46:241\u2013255.","journal-title":"Histopathology"},{"key":"62_CR5","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1097\/01.pas.0000126781.87158.e3","volume":"28","author":"L Colomo","year":"2004","unstructured":"Colomo L, Loong F, Rives S, et al.: Diffuse large B-cell lymphomas with plasmablastic differentiation represent a heterogeneous group of disease entities. Am J Surg Pathol 2004, 28:736\u2013747. Discusses and reviews distinct clinical, morphologic, and immunophenotypic features of subtypes of diffuse large B-cell lymphomas with plasmablastic differentiation.","journal-title":"Am J Surg Pathol"},{"key":"62_CR6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.0303-6987.2005.00258.x","volume":"32","author":"S Verma","year":"2005","unstructured":"Verma S, Nuovo GJ, Porcu P, et al.: Epstein-Barr virus-and human herpesvirus 8-associated primary cutaneous plasmablastic lymphoma in the setting of renal transplantation. J Cutan Pathol 2005, 32:35\u201339.","journal-title":"J Cutan Pathol"},{"key":"62_CR7","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1365-2559.2005.01985.x","volume":"46","author":"LB Jordan","year":"2005","unstructured":"Jordan LB, Lessells AM, Goodlad JR: Plasmablastic lymphoma arising at a cutaneous site. Histopathology 2005, 46:113\u2013115.","journal-title":"Histopathology"},{"key":"62_CR8","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-2559.2004.01990.x","volume":"46","author":"A Tzankov","year":"2005","unstructured":"Tzankov A, Brunhuber T, Gschwendtner A, Brunner A: Incidental oral plasmablastic lymphoma with aberrant expression of CD4 in an elderly HIV-negative patient: how a gingival polyp can cause confusion. Histopathology 2005, 46:348\u2013350.","journal-title":"Histopathology"},{"key":"62_CR9","first-page":"41","volume":"25","author":"U Zanetto","year":"2004","unstructured":"Zanetto U, Martin CA, Sapia S, et al.: Re: Cioc AM, Allen C, Kalmar J, et al. Oral plasmablastic lymphomas in AIDS patients are associated with human herpesvirus 8. Am J Surg Pathol 2004, 25:41\u201346. Am J Surg Pathol 2004, 28:1537\u20131538; author reply 1538.","journal-title":"Am J Surg Pathol"},{"key":"62_CR10","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/00000478-200401000-00003","volume":"28","author":"AM Cioc","year":"2004","unstructured":"Cioc AM, Allen C, Kalmar JR, et al.: Oral plasmablastic lymphomas in AIDS patients are associated with human herpesvirus 8. Am J Surg Pathol 2004, 28:41\u201346.","journal-title":"Am J Surg Pathol"},{"key":"62_CR11","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1097\/01.pas.0000131533.21345.1c","volume":"28","author":"A Carbone","year":"2004","unstructured":"Carbone A, Gloghini A, Gaidano G: Is plasmablastic lymphoma of the oral cavity an HHV-8-associated disease? Am J Surg Pathol 2004, 28:1251\u20131252.","journal-title":"Am J Surg Pathol"},{"key":"62_CR12","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1097\/01.pas.0000131533.21345.1c","volume":"28","author":"A Carbone","year":"2004","unstructured":"Carbone A, Gloghini A, Gaidano G: Is plasmablastic lymphoma of the oral cavity an HHV-8-associated disease? Am J Surg Pathol 2004, 28:1538\u20131540; author reply 1540.","journal-title":"Am J Surg Pathol"},{"key":"62_CR13","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1097\/01.pas.0000138177.10829.5c","volume":"28","author":"A Chadburn","year":"2004","unstructured":"Chadburn A, Hyjek E, Mathew S, et al.: KSHV-positive solid lymphomas represent an extra-cavitary variant of primary effusion lymphoma. Am J Surg Pathol 2004, 28:1401\u20131416. Discusses and reviews cases and the literature on KSHV-associated lymphomas, PELs, and solid lymphomas.","journal-title":"Am J Surg Pathol"},{"key":"62_CR14","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/sj.leu.2403709","volume":"19","author":"ST Deloose","year":"2005","unstructured":"Deloose ST, Smit LA, Pals FT, et al.: High incidence of Kaposi sarcoma-associated herpesvirus infection in HIV-related solid immunoblastic\/plasmablastic diffuse large B-cell lymphoma. Leukemia 2005, 19:851\u2013855.","journal-title":"Leukemia"},{"key":"62_CR15","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/cncr.21036","volume":"105","author":"O Lin","year":"2005","unstructured":"Lin O, Gerhard R, Zerbini MC, Teruya-Feldstein J: Cytologic features of plasmablastic lymphoma: a report of 4 cases. Cancer Cytopathol 2005, 105:139\u2013144.","journal-title":"Cancer Cytopathol"},{"key":"62_CR16","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1309\/617DWB5GNFWXHW4L","volume":"121","author":"FP O\u2019Connell","year":"2004","unstructured":"O\u2019Connell FP, Pinkus JL, Pinkus GS: CD138 (syndecan-1), a plasma cell marker immunohistochemical profile in hematopoietic and nonhematopoietic neoplasms. Am J Clin Pathol 2004, 121:254\u2013263.","journal-title":"Am J Clin Pathol"},{"key":"62_CR17","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1136\/jcp.47.5.418","volume":"47","author":"H Turley","year":"1994","unstructured":"Turley H, Jones M, Erber W, et al.: VS38: a new monoclonal antibody for detecting plasma cell differentiation in routine sections. J Clin Pathol 1994, 47:418\u2013422.","journal-title":"J Clin Pathol"},{"key":"62_CR18","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1136\/jcp.50.6.485","volume":"50","author":"AH Banham","year":"1997","unstructured":"Banham AH, Turley H, Pulford K, et al.: The plasma cell associated antigen detectable by antibody VS38 is the p63 rough endoplasmic reticulum protein. J Clin Pathol 1997, 50:485\u2013489.","journal-title":"J Clin Pathol"},{"key":"62_CR19","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1136\/jcp.49.3.205","volume":"49","author":"JH Shanks","year":"1996","unstructured":"Shanks JH, Banerjee SS: VS38 immunostaining in melanocytic lesions. J Clin Pathol 1996, 49:205\u2013207.","journal-title":"J Clin Pathol"},{"key":"62_CR20","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1046\/j.1365-2559.1997.d01-599.x","volume":"30","author":"SS Banerjee","year":"1997","unstructured":"Banerjee SS, Shanks JH, Hasleton PS: VS38 immunostaining in neuroendocrine tumours. Histopathology 1997, 30:256\u2013259.","journal-title":"Histopathology"},{"key":"62_CR21","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0344-0338(97)80038-6","volume":"193","author":"I Sulzbacher","year":"1997","unstructured":"Sulzbacher I, Fuchs M, Chott A, Lang S: Expression of VS38 in osteoblasts and stroma cells of bone tumors. Pathol Res Pract 1997, 193:613\u2013616.","journal-title":"Pathol Res Pract"},{"key":"62_CR22","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1080\/10428190410001697395","volume":"45","author":"R Lester","year":"2004","unstructured":"Lester R, Li C, Galbraith P, et al.: Improved outcome of human immunodeficiency virus-associated plasmablastic lymphoma of the oral cavity in the era of highly active antiretroviral therapy: a report of two cases. Leuk Lymphoma 2004, 45:1881\u20131885.","journal-title":"Leuk Lymphoma"},{"key":"62_CR23","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1097\/00002030-200108170-00005","volume":"15","author":"A Antinori","year":"2001","unstructured":"Antinori A, Cingolani A, Alba L, et al.: Better response to chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active antiretroviral therapy. AIDS 2001, 15:1483\u20131491.","journal-title":"AIDS"},{"key":"62_CR24","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1046\/j.1365-2141.2001.02656.x","volume":"112","author":"JT Navarro","year":"2001","unstructured":"Navarro JT, Ribera JM, Oriol A, et al.: Influence of highly active anti-retroviral therapy on response to treatment and survival in patients with acquired immunodeficiency syndromerelated non-Hodgkin\u2019s lymphoma treated with cyclophosphamide, hydroxydoxorubicin, vincristine and prednisone. Br J Haematol 2001, 112:909\u2013915.","journal-title":"Br J Haematol"},{"key":"62_CR25","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1182\/blood.V88.2.645.bloodjournal882645","volume":"88","author":"RG Nador","year":"1996","unstructured":"Nador RG, Cesarman E, Chadburn A, et al.: Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi\u2019s sarcoma-associated herpes virus. Blood 1996, 88:645\u2013656.","journal-title":"Blood"},{"key":"62_CR26","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.humpath.2003.11.005","volume":"35","author":"JL Mate","year":"2004","unstructured":"Mate JL, Navarro JT, Ariza A, et al.: Oral solid form of primary effusion lymphoma mimicking plasmablastic lymphoma. Hum Pathol 2004, 35:632\u2013635.","journal-title":"Hum Pathol"},{"key":"62_CR27","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1182\/blood.V99.7.2331","volume":"99","author":"E Oksenhendler","year":"2002","unstructured":"Oksenhendler E, Boulanger E, Galicier L, et al.: High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. Blood 2002, 99:2331\u20132336.","journal-title":"Blood"},{"key":"62_CR28","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1182\/blood-2002-02-0487","volume":"100","author":"MQ Du","year":"2002","unstructured":"Du MQ, Diss TC, Liu H, et al.: KSHV-and EBV-associated germinotropic lymphoproliferative disorder. Blood 2002, 100:3415\u20133418.","journal-title":"Blood"},{"key":"62_CR29","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1182\/blood.V95.4.1406.004k26_1406_1412","volume":"95","author":"N Dupin","year":"2000","unstructured":"Dupin N, Diss TL, Kellam P, et al.: HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood 2000, 95:1406\u20131412.","journal-title":"Blood"},{"key":"62_CR30","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1182\/blood.V97.7.2130","volume":"97","author":"MQ Du","year":"2001","unstructured":"Du MQ, Liu H, Diss TC, et al.: Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders. Blood 2001, 97:2130\u20132136.","journal-title":"Blood"},{"key":"62_CR31","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jamcollsurg.2004.03.028","volume":"199","author":"R Sharma","year":"2004","unstructured":"Sharma R, Abdou S, Plymyer MR, Rohatgi C: Disseminated plasmablastic lymphoma. J Am Coll Surg 2004, 199:654\u2013655.","journal-title":"J Am Coll Surg"},{"key":"62_CR32","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/ajh.20190","volume":"77","author":"SA Schichman","year":"2004","unstructured":"Schichman SA, McClure R, Schaefer RF, Mehta P: HIV and plasmablastic lymphoma manifesting in sinus, testicles, and bones: a further expansion of the disease spectrum. Am J Hematol 2004, 77:291\u2013295.","journal-title":"Am J Hematol"},{"key":"62_CR33","first-page":"927","volume":"10","author":"MA Vasef","year":"1997","unstructured":"Vasef MA, Medeiros LJ, Yospur LS, et al.: Cyclin D1 protein in multiple myeloma and plasmacytoma: an immunohistochemical study using fixed, paraffin-embedded tissue sections. Mod Pathol 1997, 10:927\u2013932.","journal-title":"Mod Pathol"},{"key":"62_CR34","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/path.1680","volume":"205","author":"M Kremer","year":"2005","unstructured":"Kremer M, Ott G, Nathrath M, et al.: Primary extramedullary plasmacytoma and multiple myeloma: phenotypic differences revealed by immunohistochemical analysis. J Pathol 2005, 205:92\u2013101.","journal-title":"J Pathol"},{"key":"62_CR35","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1182\/blood.V89.5.1483","volume":"89","author":"G Delsol","year":"1997","unstructured":"Delsol G, Lamant L, Mariame B, et al.: A new subtype of large B-cell lymphoma expressing the ALK kinase and lacking the 2; 5 translocation. Blood 1997, 89:1483\u20131490.","journal-title":"Blood"},{"key":"62_CR36","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1182\/blood.V95.10.3204","volume":"95","author":"C Touriol","year":"2000","unstructured":"Touriol C, Greenland C, Lamant L, et al.: Further demonstration of the diversity of chromosomal changes involving 2p23 in ALK-positive lymphoma: 2 cases expressing ALK kinase fused to CLTCL (clathrin chain polypeptide-like). Blood 2000, 95:3204\u20133207.","journal-title":"Blood"},{"key":"62_CR37","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1182\/blood-2003-03-0786","volume":"102","author":"RD Gascoyne","year":"2003","unstructured":"Gascoyne RD, Lamant L, Martin-Subero JI, et al.: ALK-positive diffuse large B-cell lymphoma is associated with Clathrin-ALK rearrangements: report of 6 cases. Blood 2003, 102:2568\u20132573.","journal-title":"Blood"},{"key":"62_CR38","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1097\/01.MP.0000081729.40230.1F","volume":"16","author":"N Chikatsu","year":"2003","unstructured":"Chikatsu N, Kojima H, Suzukawa K, et al.: ALK+, CD30-, CD20-large B-cell lymphoma containing anaplastic lymphoma kinase (ALK) fused to clathrin heavy chain gene (CLTC). Mod Pathol 2003, 16:828\u2013832.","journal-title":"Mod Pathol"},{"key":"62_CR39","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1182\/blood-2003-04-1050","volume":"102","author":"P Paepe De","year":"2003","unstructured":"De Paepe P, Baens M, van Krieken H, et al.: ALK activation by the CLTC-ALK fusion is a recurrent event in large B-cell lymphoma. Blood 2003, 102:2638\u20132641.","journal-title":"Blood"},{"key":"62_CR40","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.humpath.2004.06.001","volume":"35","author":"DT McManus","year":"2004","unstructured":"McManus DT, Catherwood MA, Carey PD, et al.: ALK-positive diffuse large B-cell lymphoma of the stomach associated with a clathrin-ALK rearrangement. Hum Pathol 2004, 35:1285\u20131288.","journal-title":"Hum Pathol"},{"key":"62_CR41","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1097\/00000478-200311000-00012","volume":"27","author":"P Adam","year":"2003","unstructured":"Adam P, Katzenberger T, Seeberger H, et al.: A case of a diffuse large B-cell lymphoma of plasmablastic type associated with the t(2;5)(p23;q35) chromosome translocation. Am J Surg Pathol 2003, 27:1473\u20131476.","journal-title":"Am J Surg Pathol"},{"key":"62_CR42","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1182\/blood-2003-04-1095","volume":"102","author":"M Onciu","year":"2003","unstructured":"Onciu M, Behm FG, Downing JR, et al.: ALK-positive plasmablastic B-cell lymphoma with expression of the NPM-ALK fusion transcript: report of 2 cases. Blood 2003, 102:2642\u20132644.","journal-title":"Blood"},{"key":"62_CR43","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/sj.leu.2403206","volume":"18","author":"I Simonitsch-Klupp","year":"2004","unstructured":"Simonitsch-Klupp I, Hauser I, Ott G, et al.: Diffuse large B-cell lymphomas with plasmablastic\/plasmacytoid features are associated with TP53 deletions and poor clinical outcome. Leukemia 2004, 18:146\u2013155.","journal-title":"Leukemia"},{"key":"62_CR44","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1097\/00000478-200206000-00005","volume":"26","author":"B Petitjean","year":"2002","unstructured":"Petitjean B, Jardin F, Joly B, et al.: Pyothorax-associated lymphoma: a peculiar clinicopathologic entity derived from B cells at late stage of differentiation and with occasional aberrant dual B- and T-cell phenotype. Am J Surg Pathol 2002, 26:724\u2013732.","journal-title":"Am J Surg Pathol"},{"key":"62_CR45","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nri1572","volume":"5","author":"M Shapiro-Shelef","year":"2005","unstructured":"Shapiro-Shelef M, Calame K: Regulation of plasma-cell development. Nat Rev Immunol 2005, 5:230\u2013242. Recent review of molecules playing a role in plasma cell development, differentiation, and regulation.","journal-title":"Nat Rev Immunol"},{"key":"62_CR46","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1128\/JVI.79.2.1296-1307.2005","volume":"79","author":"LL Laichalk","year":"2005","unstructured":"Laichalk LL, Thorley-Lawson DA: Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo. J Virol 2005, 79:1296\u20131307.","journal-title":"J Virol"},{"key":"62_CR47","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1182\/blood-2004-04-1385","volume":"105","author":"L Guedez","year":"2005","unstructured":"Guedez L, Martinez A, Zhao S, et al.: Tissue inhibitor of metalloproteinase 1 (TIMP-1) promotes plasmablastic differentiation of a Burkitt lymphoma cell line: implications in the pathogenesis of plasmacytic\/plasmablastic tumors. Blood 2005, 105:1660\u20131668.","journal-title":"Blood"},{"key":"62_CR48","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1182\/blood-2004-07-2630","volume":"105","author":"E Tiacci","year":"2005","unstructured":"Tiacci E, Orvietani PL, Bigerna B, et al.: Tumor protein D52 (TPD52): a novel B-cell\/plasma-cell molecule with unique expression pattern and Ca2+-dependent association with annexin VI. Blood 2005, 105:2812\u20132820.","journal-title":"Blood"},{"key":"62_CR49","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrc1452","volume":"4","author":"LS Young","year":"2004","unstructured":"Young LS, Rickinson AB: Epstein-Barr virus: 40 years on. Nat Rev Cancer 2004, 4:757\u2013768.","journal-title":"Nat Rev Cancer"},{"key":"62_CR50","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1182\/blood-2004-08-3052","volume":"105","author":"A Godfrey","year":"2005","unstructured":"Godfrey A, Anderson J, Papanastasiou A, et al.: Inhibiting primary effusion lymphoma by lentiviral vectors encoding short hairpin RNA. Blood 2005, 105:2510\u20132518.","journal-title":"Blood"}],"container-title":["Current Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-005-0062-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11912-005-0062-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-005-0062-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T16:52:08Z","timestamp":1587574328000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11912-005-0062-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["62"],"URL":"https:\/\/doi.org\/10.1007\/s11912-005-0062-5","relation":{},"ISSN":["1523-3790","1534-6269"],"issn-type":[{"value":"1523-3790","type":"print"},{"value":"1534-6269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,10]]}}}